Current Ratio
since 2005
Calculation
Vertex Pharmaceuticals Inc., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2023 | 3.99 | = | 14,144,200) | ÷ | 3,547,400) |
| Dec 31, 2022 | 4.83 | = | 13,234,800) | ÷ | 2,742,100) |
| Dec 31, 2021 | 4.46 | = | 9,560,600) | ÷ | 2,142,000) |
| Dec 31, 2020 | 4.33 | = | 8,133,379) | ÷ | 1,877,533) |
| Dec 31, 2019 | 3.61 | = | 4,822,829) | ÷ | 1,334,827) |
| Dec 31, 2018 | 3.43 | = | 3,843,109) | ÷ | 1,120,292) |
| Dec 31, 2017 | 3.28 | = | 2,648,963) | ÷ | 807,260) |
| Dec 31, 2016 | 2.31 | = | 1,831,540) | ÷ | 792,537) |
| Dec 31, 2015 | 2.78 | = | 1,407,153) | ÷ | 506,349) |
| Dec 31, 2014 | 4.20 | = | 1,546,511) | ÷ | 368,254) |
| Dec 31, 2013 | 3.99 | = | 1,588,576) | ÷ | 397,829) |
| Dec 31, 2012 | 3.67 | = | 1,589,585) | ÷ | 432,624) |
| Dec 31, 2011 | 3.39 | = | 1,331,254) | ÷ | 392,348) |
| Dec 31, 2010 | 2.23 | = | 1,057,039) | ÷ | 474,783) |
| Dec 31, 2009 | 4.59 | = | 1,307,026) | ÷ | 284,883) |
| Dec 31, 2008 | 4.01 | = | 867,581) | ÷ | 216,564) |
| Dec 31, 2007 | 2.49 | = | 496,851) | ÷ | 199,279) |
| Dec 31, 2006 | 3.07 | = | 771,406) | ÷ | 251,014) |
| Dec 31, 2005 | 3.84 | = | 385,055) | ÷ | 100,243) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
Comparison to Competitors
Vertex Pharmaceuticals Inc., current ratio, long-term trends, comparison to competitors
| Vertex Pharmaceuticals Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 3.99 | 0.87 | 1.65 | 1.43 | 1.68 | 0.94 | 1.43 | 1.16 | 1.25 | 3.42 | 0.91 | 5.69 | 1.75 |
| Dec 31, 2022 | 4.83 | 0.96 | 1.41 | 1.25 | 1.89 | 1.05 | 1.29 | 0.99 | 1.47 | 2.73 | 1.22 | 5.06 | 1.48 |
| Dec 31, 2021 | 4.46 | 0.79 | 1.59 | 1.52 | 1.43 | 1.23 | 1.27 | 1.35 | 1.27 | 1.76 | 1.40 | 3.56 | 1.50 |
| Dec 31, 2020 | 4.33 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.40 | 1.21 | 1.02 | 1.43 | 1.35 | 3.63 | 2.13 |
| Dec 31, 2019 | 3.61 | 3.18 | 1.44 | 1.60 | 5.19 | 1.16 | 3.10 | 1.26 | 1.24 | 7.89 | 0.88 | 3.67 | 1.92 |
| Dec 31, 2018 | 3.43 | 0.98 | 2.79 | 1.61 | 1.47 | 1.73 | 3.38 | 1.47 | 1.17 | 7.02 | 1.57 | 4.47 | 1.73 |
| Dec 31, 2017 | 3.28 | 1.28 | 5.49 | 1.55 | 1.43 | 1.32 | 2.74 | 1.41 | 1.33 | — | 1.35 | 3.82 | 1.34 |
| Dec 31, 2016 | 2.31 | 1.65 | 4.11 | 1.55 | 0.97 | 1.37 | 2.22 | 2.47 | 1.78 | — | 1.25 | 2.56 | 1.44 |
| Dec 31, 2015 | 2.78 | 1.50 | 4.44 | 1.30 | 1.27 | 1.53 | 2.50 | 2.17 | 1.55 | — | 1.49 | 3.59 | 1.38 |
| Dec 31, 2014 | 4.20 | 1.41 | 4.95 | 1.73 | 1.75 | 1.09 | 3.07 | 2.36 | 1.77 | — | 2.67 | 3.31 | 1.22 |
| Dec 31, 2013 | 3.99 | 2.59 | 3.44 | 1.52 | 2.01 | 1.47 | 1.15 | 2.20 | 2.00 | — | 2.41 | 6.01 | 3.16 |
| Dec 31, 2012 | 3.67 | 2.27 | 3.81 | 1.15 | 1.80 | 1.55 | 1.44 | 1.90 | 1.90 | — | 2.15 | 7.37 | 2.31 |
| Dec 31, 2011 | 3.39 | — | 4.80 | 1.97 | 1.50 | 1.60 | 5.53 | 2.38 | 2.04 | — | 2.06 | 4.40 | 1.55 |
| Dec 31, 2010 | 2.23 | — | 3.52 | 1.97 | 1.73 | 2.09 | 2.32 | 2.05 | 1.86 | — | 2.11 | 3.28 | 2.42 |
| Dec 31, 2009 | 4.59 | — | 4.89 | 2.21 | 1.89 | 1.90 | 2.57 | 1.82 | 1.80 | — | 1.66 | 4.55 | 2.76 |
| Dec 31, 2008 | 4.01 | — | 3.12 | 2.20 | 1.53 | 0.95 | 3.52 | 1.65 | 1.35 | — | 1.59 | 6.23 | 2.82 |
| Dec 31, 2007 | 2.49 | — | 2.11 | 1.20 | 1.40 | 2.33 | 4.11 | 1.51 | 1.23 | — | 2.15 | 2.81 | 1.93 |
| Dec 31, 2006 | 3.07 | — | 1.67 | 1.59 | 1.38 | 1.91 | 3.18 | 1.20 | 1.20 | — | 2.20 | 10.44 | 1.70 |
| Dec 31, 2005 | 3.84 | — | 2.57 | 1.78 | 1.30 | 1.89 | 6.79 | 2.48 | 1.58 | — | 1.47 | 8.46 | 1.71 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Vertex Pharmaceuticals Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Vertex Pharmaceuticals Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2023 | 3.99 | 1.26 |
| Dec 31, 2022 | 4.83 | 1.29 |
| Dec 31, 2021 | 4.46 | 1.35 |
| Dec 31, 2020 | 4.33 | 1.35 |
| Dec 31, 2019 | 3.61 | 1.66 |
| Dec 31, 2018 | 3.43 | 1.70 |
| Dec 31, 2017 | 3.28 | 1.73 |
| Dec 31, 2016 | 2.31 | 1.91 |
| Dec 31, 2015 | 2.78 | 1.90 |
| Dec 31, 2014 | 4.20 | 2.18 |
| Dec 31, 2013 | 3.99 | 2.16 |
| Dec 31, 2012 | 3.67 | 2.04 |
| Dec 31, 2011 | 3.39 | 2.29 |
| Dec 31, 2010 | 2.23 | 2.14 |
| Dec 31, 2009 | 4.59 | 1.94 |
| Dec 31, 2008 | 4.01 | 1.65 |
| Dec 31, 2007 | 2.49 | 1.74 |
| Dec 31, 2006 | 3.07 | 1.64 |
| Dec 31, 2005 | 3.84 | 1.81 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Vertex Pharmaceuticals Inc., current ratio, long-term trends, comparison to industry (health care)
| Vertex Pharmaceuticals Inc. | Health Care | |
|---|---|---|
| Dec 31, 2023 | 3.99 | 1.14 |
| Dec 31, 2022 | 4.83 | 1.16 |
| Dec 31, 2021 | 4.46 | 1.21 |
| Dec 31, 2020 | 4.33 | 1.21 |
| Dec 31, 2019 | 3.61 | 1.34 |
| Dec 31, 2018 | 3.43 | 1.38 |
| Dec 31, 2017 | 3.28 | 1.47 |
| Dec 31, 2016 | 2.31 | 1.68 |
| Dec 31, 2015 | 2.78 | 1.67 |
| Dec 31, 2014 | 4.20 | 1.87 |
| Dec 31, 2013 | 3.99 | 1.93 |
| Dec 31, 2012 | 3.67 | 1.81 |
| Dec 31, 2011 | 3.39 | 1.91 |
| Dec 31, 2010 | 2.23 | 1.80 |
| Dec 31, 2009 | 4.59 | 1.75 |
| Dec 31, 2008 | 4.01 | 1.42 |
| Dec 31, 2007 | 2.49 | 1.51 |
| Dec 31, 2006 | 3.07 | 1.39 |
| Dec 31, 2005 | 3.84 | 1.63 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).